Note: "MRSH" is the world's leading insurance broker and professional-services firm Marsh McLennan, which files under the internal ticker MMC. All fundamentals below are sourced to Marsh McLennan's filings and transcripts.
Marsh McLennan goes into Q2 as a high-quality compounder facing its toughest organic-growth backdrop in years. The debate is no longer about whether MMC executes — it's about how much soft P&C/reinsurance pricing and lower fiduciary income slow the top line, and whether the company can still deliver its signature margin expansion and high-single-digit EPS growth against that tape. Sentiment into the print is neutral-to-cautious.
Consensus for Q2 2026 clusters around:
| Metric | Q2 2026 Consensus | Q2 2025 Actual | Implied Y/Y |
|---|---|---|---|
| Underlying (organic) revenue growth | ~3.6% (RIS ~3.1%) | +4% (RIS +4%) | Decelerating |
| Adjusted operating margin | ~29.3% | 29.5% | ~flat/slightly down |
| Adjusted EPS | ~$2.90 | $2.72 | ~+6–7% |
The setup is a modest organic deceleration with roughly flat margins and mid-to-high-single-digit EPS growth — consistent with management's full-year framing but leaving little room for disappointment given the valuation and recent run in the stock.
Management framed 2026 organic growth as "similar to 2025" (2025 was ~4%), while acknowledging two persistent headwinds: declining insurance/reinsurance rates and lower fiduciary interest income. In Q1 2026: - Primary commercial insurance rates fell 5% (property down 9%), following a 4% decline in Q4 2025. MMC's index skews to large accounts. - Casualty rates rose 3% (U.S. excess casualty +18%) — a partial offset and a demand driver as loss-cost inflation runs ~2x GDP. - RIS organic was +3% in Q1, with Marsh Risk +4% and Guy Carpenter just +2%.
Watch: Marsh Risk organic (Q1 was +4%; U.S./Canada +3%, International +5%), and whether MMA (middle market) and specialty/construction/transaction-risk new business continue to offset rate softness.
This is likely the softest spot. Guy Carpenter grew only 2% organic in Q1 against a tough +5% comp, and Q2 laps another +5% from last year. Management flagged Japan (April 1) and Florida (June 1) property-cat renewals with rates down 15–20% and "excess supply." Doyle has openly said this "is not likely to be Guy Carpenter's best growth year." Don't be surprised by low-single-digit (or lower) organic here; the question is whether record new business and cat-bond/ILS issuance cushion it.
MMC has expanded adjusted margins 18 consecutive years and reaffirmed year 19 for 2026. Two important modeling nuances from management: - Margin expansion is weighted to 2H 2026 — so a flattish-to-slightly-lower Q2 margin (~29.3% vs. 29.5% a year ago) would not necessarily break the thesis. - The Thrive program ($400M gross savings, ~$500M of charges) and AI/BCS (Business & Client Services) automation are the levers funding both margins and reinvestment.
Management is aggressively positioning MMC as an "AI winner" across three pillars — growth (Aida, Sentrisk, Euclid, GC QuoteBox, Oliver Wyman's "Quotient"), productivity, and efficiency (BCS). The bull case: scale + proprietary data + trusted-advisor relationships. The bear case investors keep pressing: disintermediation risk and whether AI productivity gains get competed away vs. retained as margin. Expect more of this on the call; watch for any quantification of savings or revenue.
From the Q1 2026 call, MMC pre-guided several Q2 line items: - Fiduciary interest income: ~$80M (a headwind; was $99M in Q2 2025) — a direct drag on high-margin revenue. - Corporate expense: ~$90M, including some one-off timing items (up from $74M in Q1). - Interest expense: ~$245M. - FX: immaterial for Q2 and rest of year. - 2026 adjusted tax rate: 24.5%–25.5% (Q1 was 25.1%). Watch for discrete items that can swing reported EPS.
MMC shares have recovered meaningfully into the print, rising from roughly $162 in early June to ~$182 by July 20 (~+12%). That rebound raises the bar: after de-rating with the broker group earlier, the stock is entering the report with momentum, so a merely "in-line" organic number against decelerating trends could be treated harshly. Conversely, resilient Marsh Risk organic, reaffirmed year-19 margin expansion, and steady capital return would support the quality-compounder narrative.
Positive: Marsh Risk organic holding ≥4%; total organic at/above ~3.6%; margins flat-to-up with reaffirmed 2H-weighted expansion and full-year "similar to 2025" organic; larger buyback; concrete AI efficiency/revenue proof points.
Negative: Organic slipping toward ~3% (especially if Guy Carpenter and Mercer/Career soften together); any hint that full-year organic guide is at risk; margin pressure not clearly explained by known Q2 one-offs (corporate expense, fiduciary income); incremental Greensill or litigation escalation.
Net: expect a "solid-but-slowing" quarter. The report is less about the Q2 headline EPS beat (a modest one is likely) and more about management's tone on the full-year organic trajectory, the margin cadence, and the AI/capital-return story that underpins the premium multiple.
Preview based on MMC's Q1 2026 earnings call (April 16, 2026), Q2 2025 earnings release, and July 2026 pre-earnings market commentary. Consensus figures are Street estimates as of mid-July 2026 and may differ from final reported results.